Introduction
Parenteral formulations, including injectable drugs, require strict control of moisture content to ensure product safety, stability, and efficacy. Water content can directly impact formulation integrity, sterility, and shelf life.
Karl Fischer titration provides a precise and reliable method for determining moisture content in parenteral pharmaceutical products.
Analytical Challenge
Parenteral formulations present unique analytical challenges:
- Very low moisture limits in certain formulations
- Sensitivity to contamination and environmental exposure
- Need for highly accurate and reproducible results
These factors require sensitive and reliable analytical techniques.
Recommended Method
Karl Fischer titration is widely used for moisture determination in parenteral formulations:
- Coulometric Karl Fischer for trace moisture analysis
- Volumetric Karl Fischer for higher water content
For advanced pharmaceutical applications, modern systems provide improved control and flexibility.
Typical Procedure
- Prepare sample under controlled conditions
- Introduce sample into Karl Fischer system
- Perform titration using appropriate method
- Record and validate results
Results and Benefits
- Accurate and reliable moisture determination
- Suitable for critical pharmaceutical applications
- High reproducibility and sensitivity
- Supports regulatory compliance
Recommended Instrumentation
- Moico-A19 Coulometric Karl Fischer Titrator (advanced pharmaceutical applications, high sensitivity and precision)
- Moivo-A19 Volumetric Karl Fischer Titrator (flexibility across moisture ranges)
- AQ-300 / AQV-300 Karl Fischer Titrators (cost-effective solutions for routine analysis)
Conclusion
Karl Fischer titration provides a robust and reliable method for moisture determination in parenteral formulations. Advanced systems such as the A19 platform offer enhanced performance for pharmaceutical laboratories requiring precision and flexibility.
Related Applications
Moisture Determination in Tablet Formulations
Moisture Determination in Active Pharmaceutical Ingredients (APIs)
Water Content in Lyophilized Pharmaceutical Products
